Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions

American Journal of Kidney Diseases

Volumn 54, Issue 4, 2009, Pages 711-720

  Han, Seung Hyeok ^a,b   Ahn, Song Vogue ^a   Yun, Jee Young ^c   Tranaeus, Anders ^d   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c BAXTER HEALTHCARE CORPORATION   (United States)

^d Baxter Asia Pacific   (China)

Author keywords

bicarbonate lactate; Biocompatibility; icodextrin; low glucose degradation product (GDP); peritoneal dialysis

Indexed keywords

BICARBONATE; BICARBONATE PLUS LACTATE SOLUTION; ICODEXTRIN; PERITONEAL DIALYSIS FLUID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; RISK REDUCTION; SCORING SYSTEM; SOCIAL STATUS; SURVIVAL; TREATMENT FAILURE;

ADULT; AGED; BLOOD GLUCOSE; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY DISEASES; KOREA; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349382812     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.05.014     Document Type: Article

References (33)

1. Topley N. Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 5 (1998) 179-184
2. Hoff C.M. In vitro biocompatibility performance of Physioneal. Kidney Int Suppl 88 (2003) S57-S74
3. Higuchi C., Nishimura H., and Sanaka T. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis. Ther Apher Dial 10 (2006) 372-379
4. Witowski J., Wisniewska J., Korybalska K., et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12 (2001) 2434-2441
5. Mortier S., De Vriese A.S., McLoughlin R.M., et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 14 (2003) 1296-1306
6. Witowski J., Korybalska K., Wisniewska J., et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 11 (2000) 729-739
7. Morgan L.W., Wieslander A., Davies M., et al. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 64 (2003) 1854-1866
8. Mortier S., Faict D., Schalkwijk C.G., Lameire N.H., and De Vriese A.S. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 66 (2004) 1257-1265
9. Mortier S., Faict D., Lameire N.H., and De Vriese A.S. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 67 (2005) 1559-1565
10. Honda K., Nitta K., Horita S., et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14 (1999) 1541-1549
11. Zeier M., Schwenger V., Deppisch R., et al. Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation?. Kidney Int 63 (2003) 298-305
12. Skoufos L., Topley N., Cooker L., et al. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid. Kidney Int Suppl 88 (2003) S94-S99
13. Kim C.D., Kwon H.M., Park S.H., et al. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Ther Apher Dial 11 (2007) 56-64
14. Jones S., Holmes C.J., Krediet R.T., et al. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59 (2001) 1529-1538
15. Ha H., Cha M.K., Choi H.N., and Lee H.B. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22 (2002) 171-177
16. Witowski J., Korybalska K., Ksiazek K., et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 19 (2004) 917-924
17. Gum P.A., Thamilarasan M., Watanabe J., Blackstone E.H., and Lauer M.S. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis. JAMA 286 (2001) 1187-1194
18. Lee H.Y., Park H.C., Seo B.J., et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 25 (2005) 248-255
19. Lee H.Y., Choi H.Y., Park H.C., et al. Changing prescribing practice in CAPD patients in Korea: Increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 21 (2006) 2893-2899
20. Fabbrini P., Zareie M., Ter Wee P.M., Keuning E.D., Beelen R.H., and van den Born J. Peritoneal exposure model in the rat as a tool to unravel bio(in)compatibility of PDF. Nephrol Dial Transplant 21 suppl 2 (2006) Sii8-Sii11
21. Williams J.D., Topley N., Craig K.J., et al. The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66 (2004) 408-418
22. Szeto C.C., Chow K.M., Lam C.W., et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products-A 1-year randomized control trial. Nephrol Dial Transplant 22 (2007) 552-559
23. Wang A.Y., and Lai K.N. The importance of residual renal function in dialysis patients. Kidney Int 69 (2006) 1726-1732
24. Fan S.L., Pile T., Punzalan S., Raftery M.J., and Yaqoob M.M. Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function. Kidney Int 73 (2008) 200-206
25. le Poole C.Y., van Ittersum F.J., Weijmer M.C., Valentijn R.M., and ter Wee P.M. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: A randomized crossover study. Adv Perit Dial 20 (2004) 170-176
26. Kuriyama R., Tranaeus A., and Ikegami T. Icodextrin reduces mortality and the drop-out rate in Japanese peritoneal dialysis patients. Adv Perit Dial 22 (2006) 108-110
27. Davies S.J., Woodrow G., Donovan K., et al. Icodextrin improves the fluid status of peritoneal dialysis patients: Results of a double-blind randomized controlled trial. J Am Soc Nephrol 14 (2003) 2338-2344
28. Mistry C.D., Gokal R., and Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory peritoneal dialysis. Kidney Int 46 (1994) 496-503
29. Davies S.J., Brown E.A., Frandsen N.E., et al. Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 67 (2005) 1609-1615
30. Gokal R., Moberly J., Lindholm B., and Mujais S. Metabolic and laboratory effects of icodextrin. Kidney Int Suppl 81 (2002) S62-S71
31. Barre D.E., Chen C., Cooker L., and Moberly J.B. Decreased in vitro formation of AGEs with extraneal solution compared to dextrose-containing peritoneal dialysis solutions. Adv Perit Dial 15 (1999) 12-16
32. Lo W.K. Effect of PD solutions on patient outcome. Contrib Nephrol 150 (2006) 90-96
33. Goodkin D.A., Young E.W., Kurokawa K., Prutz K.G., and Levin N.W. Mortality among hemodialysis patients in Europe, Japan, and the United States: Case-mix effects. Am J Kidney Dis 44 (2004) 16-21